Indirect Growth Inhibition of the MDA‐MB‐231 Hormone‐independent Breast Cancer Cell Line by Dihydrotestosterone
暂无分享,去创建一个
[1] A. Pizzini,et al. 5-En-androstene-3 beta,17 beta-diol inhibits the growth of MCF-7 breast cancer cells when oestrogen receptors are blocked by oestradiol. , 1994, British Journal of Cancer.
[2] N. Olsen,et al. Testosterone induces expression of transforming growth factor-beta1 in the murine thymus , 1993, The Journal of Steroid Biochemistry and Molecular Biology.
[3] M. Aragno,et al. Opposite effects of dehydroepiandrosterone on the growth of 7,12-dimethylbenz(a)anthracene-induced rat mammary carcinomas. , 1992, Anticancer research.
[4] A. Pizzini,et al. Influence of dehydroepiandrosterone and 5-en-androstene-3 beta, 17 beta-diol on the growth of MCF-7 human breast cancer cells induced by 17 beta-estradiol. , 1992, Anticancer research.
[5] F. Labrie,et al. Additive inhibitory effects of an androgen and the antiestrogen EM-170 on estradiol-stimulated growth of human ZR-75-1 breast tumors in athymic mice. , 1991, Cancer research.
[6] B. Komm,et al. High-affinity androgen binding and androgenic regulation of alpha 1(I)-procollagen and transforming growth factor-beta steady state messenger ribonucleic acid levels in human osteoblast-like osteosarcoma cells. , 1991, Endocrinology.
[7] S. Robinson,et al. The paracrine stimulation of MCF-7 cells by MDA-MB-231 cells: possible role in antiestrogen failure. , 1989, European journal of cancer & clinical oncology.
[8] R. Dickson,et al. Mechanisms of normal and malignant breast epithelial growth regulation. , 1989, Journal of steroid biochemistry.
[9] R. Derynck,et al. Evidence that transforming growth factor-β is a hormonally regulated negative growth factor in human breast cancer cells , 1987, Cell.
[10] R. Dickson,et al. Estrogenic regulation of growth and polypeptide growth factor secretion in human breast carcinoma. , 1987, Endocrine reviews.
[11] R. Dickson,et al. Induction of epidermal growth factor-related polypeptides by 17 beta-estradiol in MCF-7 human breast cancer cells. , 1986, Endocrinology.
[12] G. Shaw,et al. Molecular biology of human T-lymphotropic retroviruses. , 1985, Cancer research.
[13] B. Edwards,et al. Evaluation of tamoxifen doses with and without fluoxymesterone in advanced breast cancer. , 1983, Annals of internal medicine.
[14] B. Kennedy. Fluoxymesterone therapy in advanced breast cancer. , 1958, The New England journal of medicine.